411 related articles for article (PubMed ID: 16369332)
1. Omalizumab: a monoclonal anti-IgE antibody.
Belliveau PP
MedGenMed; 2005 Jan; 7(1):27. PubMed ID: 16369332
[TBL] [Abstract][Full Text] [Related]
2. Omalizumab: anti-IgE monoclonal antibody E25, E25, humanised anti-IgE MAb, IGE 025, monoclonal antibody E25, Olizumab, Xolair, rhuMAb-E25.
BioDrugs; 2002; 16(5):380-6. PubMed ID: 12408744
[TBL] [Abstract][Full Text] [Related]
3. Evaluation of omalizumab from a health plan perspective.
Belliveau PP; Lahoz MR
J Manag Care Pharm; 2005; 11(9):735-45. PubMed ID: 16300417
[TBL] [Abstract][Full Text] [Related]
4. Anti-IgE monoclonal antibody (omalizumab) in the treatment of atopic asthma and allergic respiratory diseases.
D'Amato G; Liccardi G; Noschese P; Salzillo A; D'Amato M; Cazzola M
Curr Drug Targets Inflamm Allergy; 2004 Sep; 3(3):227-9. PubMed ID: 15379589
[TBL] [Abstract][Full Text] [Related]
5. Anti-immunoglobulin E treatment with omalizumab in allergic diseases: an update on anti-inflammatory activity and clinical efficacy.
Holgate ST; Djukanović R; Casale T; Bousquet J
Clin Exp Allergy; 2005 Apr; 35(4):408-16. PubMed ID: 15836747
[TBL] [Abstract][Full Text] [Related]
6. Omalizumab. A review of the new treatment of allergic asthma and seasonal allergic rhinitis.
Félix Toledo R; Negro Alvarez JM; Miralles López JC
Allergol Immunopathol (Madr); 2002; 30(2):94-9. PubMed ID: 11958741
[TBL] [Abstract][Full Text] [Related]
7. Spotlight on omalizumab in allergic asthma.
Bang LM; Plosker GL
BioDrugs; 2004; 18(6):415-8. PubMed ID: 15571425
[TBL] [Abstract][Full Text] [Related]
8. Omalizumab : other indications and unanswered questions.
Mankad VS; Burks AW
Clin Rev Allergy Immunol; 2005 Aug; 29(1):17-30. PubMed ID: 16222081
[TBL] [Abstract][Full Text] [Related]
9. Omalizumab in asthma: approval and postapproval experience.
Chiang DT; Clark J; Casale TB
Clin Rev Allergy Immunol; 2005 Aug; 29(1):3-16. PubMed ID: 16222080
[TBL] [Abstract][Full Text] [Related]
10. A recombinant humanized anti-IgE monoclonal antibody (omalizumab) in the therapy of moderate-to-severe allergic asthma.
D'Amato G; Piccolo A; Salzillo A; Noschese P; D'Amato M; Liccardi G
Recent Pat Inflamm Allergy Drug Discov; 2007 Nov; 1(3):225-31. PubMed ID: 19075985
[TBL] [Abstract][Full Text] [Related]
11. Omalizumab and the treatment of allergic rhinitis.
Kaliner MA
Curr Allergy Asthma Rep; 2004 May; 4(3):237-44. PubMed ID: 15056407
[TBL] [Abstract][Full Text] [Related]
12. Omalizumab for asthma in adults and children.
Normansell R; Walker S; Milan SJ; Walters EH; Nair P
Cochrane Database Syst Rev; 2014 Jan; 2014(1):CD003559. PubMed ID: 24414989
[TBL] [Abstract][Full Text] [Related]
13. Treatment of childhood asthma with anti-immunoglobulin E antibody (omalizumab).
Milgrom H; Berger W; Nayak A; Gupta N; Pollard S; McAlary M; Taylor AF; Rohane P
Pediatrics; 2001 Aug; 108(2):E36. PubMed ID: 11483846
[TBL] [Abstract][Full Text] [Related]
14. Targeting immunoglobulin E as a novel treatment for asthma.
Sandström T
Curr Allergy Asthma Rep; 2005 Mar; 5(2):109-15. PubMed ID: 15683610
[TBL] [Abstract][Full Text] [Related]
15. Omalizumab: efficacy in allergic disease.
Spector S
Panminerva Med; 2004 Jun; 46(2):141-8. PubMed ID: 15507883
[TBL] [Abstract][Full Text] [Related]
16. Anti-IgE antibodies for the treatment of asthma.
Buhl R
Curr Opin Pulm Med; 2005 Jan; 11(1):27-34. PubMed ID: 15591885
[TBL] [Abstract][Full Text] [Related]
17. What is new in antiimmunoglobulin E asthma therapy.
Berger WE
Allergy Asthma Proc; 2005; 26(6):428-34. PubMed ID: 16541964
[TBL] [Abstract][Full Text] [Related]
18. Anti-IgE for chronic asthma in adults and children.
Walker S; Monteil M; Phelan K; Lasserson TJ; Walters EH
Cochrane Database Syst Rev; 2004; (3):CD003559. PubMed ID: 15266491
[TBL] [Abstract][Full Text] [Related]
19. Experience with monoclonal antibodies in allergic mediated disease: seasonal allergic rhinitis.
Casale TB
J Allergy Clin Immunol; 2001 Aug; 108(2 Suppl):S84-8. PubMed ID: 11498678
[TBL] [Abstract][Full Text] [Related]
20. Omalizumab.
Easthope S; Jarvis B
Drugs; 2001; 61(2):253-60; discussion 261. PubMed ID: 11270941
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
